MEDICURE INC
MCUJF · OTCMCIK 1133519fmd_15QBMQAG5W0GG9788T20SGM11SManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2015 to Dec 31, 2025, 13 periods
| Line item | FY2015 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 22 | 29 | 27 | 29 | 20 | 12 | 22 | 23 | 22 | 22 |
| Cost of revenue | 2 | 4 | 3 | 4 | 7 | 6 | 9 | 7 | 8 | 9 |
| Gross profit | 20 | 26 | 24 | 25 | 13 | 5 | 13 | 16 | 14 | 13 |
| Research and development | 5 | 4 | 5 | 7 | 4 | 3 | 2 | 3 | 2 | 3 |
| Selling, general and administrative | 10 | 15 | 15 | 20 | 17 | 10 | 13 | 12 | 12 | 13 |
| Operating income | 5 | 7 | 4 | (1) | – | – | – | – | – | – |
| Interest expense | 4 | 2 | 1 | – | – | – | – | – | – | – |
| Income before taxes | 1 | 4 | 2 | 5 | (20) | (7) | (1) | 1 | (1) | (1) |
| Income tax expense | 0 | 0 | (9) | 1 | 0 | 0 | 0 | (0) | (0) | (0) |
| Net income from continuing operations | 2 | 4 | 11 | 4 | (20) | (7) | (1) | 1 | (1) | (1) |
| Net income | 2 | 27 | 43 | 4 | (20) | (7) | (1) | 1 | (1) | (1) |